SPY411.49+2.97 0.73%
DIA337.86+2.73 0.81%
IXIC13,900.19+70.88 0.51%

BRIEF-Praxis Precision Medicines Reports Qtrly Loss Per Share $0.87

· 03/17/2021 07:42
BRIEF-Praxis Precision Medicines Reports Qtrly Loss Per Share $0.87

- Praxis Precision Medicines Inc PRAX.O:

  • PRAXIS PRECISION MEDICINES PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS

  • CASH BALANCE OF $296.6 MILLION AS OF DECEMBER 31, 2020 SUPPORTS CASH RUNWAY INTO 4Q22

  • PRAX-114 PHASE 2/3 CLINICAL TRIAL FOR TREATMENT OF MDD TO INITIATE IN MARCH 2021 FOLLOWING IND CLEARANCE

  • PRAX-944 PHASE 2A HIGH DOSE COHORT TOPLINE DATA EXPECTED IN MID-YEAR 2021

  • QTRLY LOSS PER SHARE $0.87

  • Q4 EARNINGS PER SHARE VIEW $-0.38 -- REFINITIV IBES DATA

Source text for Eikon: ID:nGNX4mnN6Y

Further company coverage: PRAX.O


((Reuters.Briefs@thomsonreuters.com;))